Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Karuna Therapeutics Inc (NQ: KRTX )

120.65 +2.89 (+2.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 28, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 520,729
Open 118.92
Bid (Size) 110.00 (3)
Ask (Size) 180.00 (5)
Prev. Close 117.76
Today's Range 114.63 - 121.74
52wk Range 92.26 - 161.98
Shares Outstanding 29,882,727
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
JMP Views Positive Phase 3 Data Equivalent To 'Schizophrenia Blockbuster' For This Stock
 
Via Benzinga
Analyst Ratings for Karuna Therapeutics
Analysts have provided the following ratings for Karuna Therapeutics (NASDAQ:KRTX) within the last quarter: 
Via Benzinga

Performance

YTD
-8.85%
-8.85%
1 Month
+15.65%
+15.65%
3 Month
-3.19%
-3.19%
6 Month
-7.88%
-7.88%
1 Year
-1.27%
-1.27%

More News

Read More
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Karuna Therapeutics, Inc. with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Karuna Therapeutics to Present at Upcoming Investor Conferences
From Karuna Therapeutics, Inc.
Via Business Wire
Analyst Ratings for Karuna Therapeutics
Via Benzinga
Karuna Therapeutics: Q1 Earnings Insights
Via Benzinga
Mizuho Sees Compelling Risk/Reward For This Schizophrenia Stock Despite Recent Weakness
Via Benzinga
Karuna Therapeutics to Host Virtual Event Highlighting Clinical Program for Psychosis in Alzheimer’s Disease
From Karuna Therapeutics, Inc.
Via Business Wire
Karuna Therapeutics Reports First Quarter 2022 Financial Results and Provides General Business Update
From Karuna Therapeutics, Inc.
Via Business Wire
Karuna Therapeutics to Present at the 2022 RBC Capital Markets Global Healthcare Conference
From Karuna Therapeutics, Inc.
Via Business Wire
What 4 Analyst Ratings Have To Say About Karuna Therapeutics
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2022
Via Benzinga
Amid Russia's Invasion On Ukraine, Karuna Therapeutics Withdraws Guidance On Late-Stage Schizophrenia Trial
Via Benzinga
Karuna Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides General Business Update
From Karuna Therapeutics, Inc.
Via Business Wire
Karuna Therapeutics to Present at the SVB Leerink 11th Annual Global Healthcare Conference
From Karuna Therapeutics, Inc.
Via Business Wire
Karuna Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
From Karuna Therapeutics, Inc.
Via Business Wire
This Metaverse Stock Will Be Featured On 'Mad Money' Wednesday Night
Via Benzinga
Karuna Therapeutics Appoints Charmaine Lykins as Chief Commercial Officer
From Karuna Therapeutics, Inc.
Via Business Wire
Week In Review: Zai Lab Announces Two In-Licensings With Total Value Of $800 Million
Via Talk Markets
Why Karuna Therapeutics Stock Tumbled This Week
Via The Motley Fool
Zai Lab Inks Back To Back Licensing Agreements For Cancer And Psychiatric Candidates
Via Benzinga
76 Biggest Movers From Yesterday
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
PureTech Founded Entity Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China
From PureTech Health plc
Via Business Wire
Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China
From Karuna Therapeutics, Inc.
Via Business Wire
Karuna Therapeutics to Present at Upcoming Investor Conferences
From Karuna Therapeutics, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.